These findings suggest that peripheral inhibition of the pro-inflammatory PGE2-EP2 signalling pathway is sufficient to decrease intestinal inflammation and restore healthy gut functions in aging mice after stroke. I suggest that myeloid cell reprogramming from EP2 blockade in the periphery improves immune cell responses in the aged gut that further improves neurological recovery, and call for similar validation and exploration in human-focused studies.
These results are exciting, since they imply that reprogramming myeloid cells to rejuvenate immune responses in the aged gut, may improve post-stroke inflammation. This could be a compelling approach to treat many other age-associated diseases.
References
1 Doyle, K. P., Fathali, N., Siddiqui, M. R. & Buckwalter, M. S. Distal hypoxic stroke: a new mouse model of stroke with high throughput, low variability and a quantifiable functional deficit. J Neurosci Methods 207, 31-40 (2012).
2 Liu, Q. et al. Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity. Nat Immunol 20, 1023-1034 (2019).
3 Stanley, D. et al. Translocation and dissemination of commensal bacteria in post-stroke infection. Nat Med 22, 1277-1284 (2016).
4 Minhas, P. S. et al. Restoring metabolism of myeloid cells reverses cognitive decline in ageing. Nature 590, 122-128 (2021).
5 Johansson, J. U. et al. Suppression of inflammation with conditional deletion of the prostaglandin E2 EP2 receptor in macrophages and brain microglia. J Neurosci 33, 16016-16032 (2013).
6 Johansson, J. U. et al. Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. J Clin Invest 125, 350-364 (2015).
7 Liu, Q. et al. PGE2 signaling via the neuronal EP2 receptor increases injury in a model of cerebral ischemia. Proc Natl Acad Sci U S A 116, 10019-10024 (2019).